December 2015, and analyzed the prognostic factors associated with tuberculosis-related death. Non-tuberculosis-related death was regarded as a competing risk.
performance status, a lower swallowing function, a lower oxygenation level and a lower serum albumin level in comparison to survivors. A competing risk regression analysis showed that a poor performance status (estimated sub-hazard ratio: 3.21, 95% CI 1.72-5.99, P < 0.001) and a low serum albumin level (estimated sub-hazard ratio: 0.33, 95% CI 0.15-0.74, P = 0.007) were significantly associated with tuberculosisrelated death. Swallowing dysfunction had no effect on tuberculosisrelated death.
Conclusion: This study revealed that a poor performance status and a lower serum albumin level predicted a poor prognosis among elderly patients with lung tuberculosis. Recent studies demonstrated that swallowing dysfunction significantly affected the prognosis of patients with community-acquired pneumonia. In contrast, the presence of swallowing dysfunction on admission did not appear to influence the mortality of patients with lung tuberculosis. Background and Aims: Chest radiography usually has been used as the first diagnostic method when a person is suggested as pulmonary tuberculosis (PTB). Despite its advantage, chest radiography as the first diagnostic test for the diagnosis of active PTB is limited by poor specificity and reader inconsistency. Chest computed tomography (CT) provide more accurate information of presumptive PTB patients. However, there are no study suggesting a correlation of radiologic activities and microbiologic culture of mycobacterium tuberculosis (MTB) via bronchoscopy.
Methods:
We retrospectively reviewed the records of all patients who underwent bronchoscopy because of suspected PTB between January 2012 and February 2015. All patients performed bronchoscopic washing or BAL and underwent AFB stain and culture, TB-PCR and gram stain. Using radiological criteria for determine radiologic activities on CT, we classified our patients in 4 groups.
Results: Of 459 patients included, 204 had positive culture of MTB.
Median age was 56.92 17.5. 272 were finally diagnosed as pulmonary tuberculosis and 39 patients were nontuberculosis mycobacterium (NTM), 82 patients were pneumonia and 66 patients were other. Radiographic activities of our patients are 139 (30.3%) were definitely active, 189 (41.2%) were Probably active, 75 (16.3%) were Indeterminate activity and 56 (12.2%) were Probably inactive. There were significant correlation between the radiographic activity and culture-positive of MTB.
Conclusion:
Our study suggests that radiologic activities based on chest CT findings correlated with the microbiologic diagnosis in patients with pulmonary tuberculosis. And chest CT is useful for diagnose radioactivity of pulmonary tuberculosis. Background and Aims: The tuberculosis incidence in Indonesia is the second largest in the world. It is still unclear how the role of cytokines to make the severity of the disease. Interferon-γ (IFN-γ) and Interleukin-17 (IL-17) are important cytokines in the immune response against Mycobacterium tuberculosis both in Rifampicin (Rif )-resistance and Rif-sensitive. This study aims was to determine the difference of these cytokines level in Rif-resistance and Rif-sensitive pulmonary tuberculosis (PTB) patients and their effect to form severity of the chest radiographic interpretation.
Methods: A descriptive analytic study. Fifty-eight subjects were selected: 27 Rif-resistance, 22 Rif-sensitive PTB patients and 9 healthy control (HC). Interferon-γ and IL-17 concentration was determined by
Results: The level of INF-γ in Rif-Resistance vs Rif-sensitive PTB was 439.8 AE 52.029 pg/mL vs 336.68 AE 11.951 gp/mL and IL-17 level was 4.39 AE .986 pg/mL vs 4.0 AE .935 pg/mL. The level of IFN-γ was 81.3 AE 6.33 pg/mL and IL-17 was 2.3 AE ,32 pg/mL in HC. Both cytokines were not significantly different among all PTB patients (P >0.05) but significantly different from healthy control (P < 0.05). The level of IFN-γ in Rif-resistance and Rif-sensitive PTB to form severity of chest radiographs was not significantly different (P > 0.05). Neither with IL-17 level in Rifresistance and Rif-sensitive PTB (P > 0.05).
The level of IFN-γ and IL-17 were not significantly different in both Rif-Resistance and Rif-sensitive PTB patients but significantly different from HC. Interferon-γ and IL-17 had a low correlation to established the severity of chest radiograph both in Rif-Resistance and Rif sensitive PTB patients, although it were not significantly different. These two cytokines cannot be used to distinguish chest radiograph severity in Rifresistance and Rif-sensitive PTB patients. Background and Aims: Although it is necessary to culture Mycobacterium tuberculosis from tuberculous lymphadenitis (TBL) to enable clinicians to tailor the therapy, based on the drug-sensitivity test (DST), substantial numbers of TBL remain culture-negative. Limited data are available regarding the treatment outcomes and recurrence rates after standard short-course anti-tuberculosis treatment in patients with culturenegative TBL. The aim of this study was to compare treatment outcomes and recurrence rates between a tailored anti-tuberculosis regimen based on individual DST result and a standard anti-tuberculosis regimen due to unavailable DST because of culture-negative in TBL patients.
Methods:
We analysed the data of all patients with TBL from the TB registry database at five hospitals of Hallym Medical center, South Korea, during 2011-2015. The study population was divided into two groups according to regimen.
Results: Tailored and Standard anti-tuberculosis therapy were administered to respectively 44 and 163 patients with TBL. Drug resistance was detected in 3 (6.8 %) of patients with TBL, one case whom was multidrug-resistant. The treatment completion rate was not significantly different between the two groups (97.8 % vs 98.7 %). During a median 28-months follow-up, the recurrence rate was also similar in both groups (2.2 % vs 2.4 %).
Conclusion: Despite several limitations, these results support the hypothesis that immunocompetent patients with culture-negative TBL can be appropriately managed with a standard short-course anti-tuberculosis regimen, in this era of not increasing concerns about drug resistance. Background and Aims: Global data showed the high rates of Tuberculosis Diabetic Mellitus (TB-DM) incidence in the world, Asia as well as in Indonesia. Neutrophil-lymphocyte ratio (NLR) is a laboratory marker that can be used for systemic inflammation in TB-DM and also it is an available and cost-effective biomarker used in clinical practice that has been associated with recurrence and survival in various diseases, one of them TB-DM. It is necessary to cut off point NLR in TB-DM to know disease activity in Tuberculosis and Diabetic Mellitus Patients. The aim of our study is to investigate the value of neutrophil-to-lymphocyte ratio (NLR) as a possible marker to know disease activity in Tuberculosis and Diabetic Mellitus Patients.
Methods: This study is a retrospective cohort study with using secondary data between January 2016 and March 2018 taken with consecutive sampling in Cipto Mangunkusumo National Center General Hospital, Indonesia. Sampling was done by consecutive sampling with 181 patient.
This study was analysed with descriptive analysis and ROC curve.
Result: Among the 181 patients in this study, 89 (49%) had TB-DM and 92 (51%) had TB non DM with complete neutrophil and lymphocyte data available. The area under curve ROC 0,726 with 95% CI got the cut of point NLR was 2.9. Patient with NLR > 2.9 (N = 100) and < 2.9 (N = 81).
Conclusion : In conclusion, NLR has attracted attention as a new inflammatory marker. The best cut-off value of NLR was 2.9 in predicting disease activity TBDM patients and this displayed a sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy value (67, 66, 61.7, 71.7 and 66.8) . The patient with NLR < 2.9 has immunocompetent and > 2.9 has immunocompromise. Many factors affect NLR was associated with disease activity in TB-DM. 
